A New Option for the Management of Dyslipidemias: Advances in Research on the Small Interfering RNA Drug Inclisiran. [PDF]
Wu X, Zhang J.
europepmc +1 more source
Inverted L-shape association between a body shape index and peak expiratory flow among middle-aged and older adults: findings from the China Health and Retirement Longitudinal Study (CHARLS). [PDF]
Jiang G, Feng L, Qu X, Wang J, Li Y.
europepmc +1 more source
CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia. [PDF]
Mondal A, Misra A.
europepmc +1 more source
Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics. [PDF]
Muhammad AA +4 more
europepmc +1 more source
Bempedoic acid in a high-risk primary-prevention patient unable to take statins: a case-based approach. [PDF]
Barańska N +4 more
europepmc +1 more source
Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022. [PDF]
Rivadeneira J +5 more
europepmc +1 more source
A Remote Chronic Disease Management Program to Improve Cardiovascular and Metabolic Outcomes in a Diverse Community-Based Diabetic Population: Study Design of the TAMIS Trial. [PDF]
Barros RC +22 more
europepmc +1 more source

